Advertisement

Muscle Mass Versus Muscle Strength and Performance: Is Muscle Mass Measurement Alone Enough?

  • Matthew R. KappusEmail author
  • Pranab Barman
Chapter

Abstract

In the world of advanced liver disease, no person can deny the loss of physical function that occurs to patients with cirrhosis. As the disease progresses, the physical manifestations of muscle mass loss and reduced physical function are apparent. Providers, patients, and caregivers to patients know this all too well. Unfortunately, however, this highly devastating physical manifestation is evaluated in a subjective manner at the current time. At best these assessments are inaccurate, at worse unequitable. Whether in the research or clinical settings, sarcopenia and frailty may be useful biomarkers to study reduction in physical function and worsened outcomes in patients awaiting liver transplantation. Each is linked to morbidity and mortality and is useful in different clinical scenarios. Here, we examine more closely the similarities and differences between sarcopenia and frailty.

Keywords

Sarcopenia Strength Function Performance Cirrhosis Liver disease Frailty Mortality Morbidity Transplantation 

References

  1. 1.
    Berman K, Tandra S, Forssell K, Vuppalanchi R, Burton JR, Nguyen J, et al. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. Clin Gastroenterol Hepatol. 2011;9:254–9.CrossRefGoogle Scholar
  2. 2.
    Bhanji RA, Carey EJ, Yang L, Watt KD. The long winding road to transplant: how sarcopenia and debility impact morbidity and mortality on the waitlist. Clin Gastroenterol Hepatol. 2017;15:1492–7.CrossRefGoogle Scholar
  3. 3.
    Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg. 2010;211:271–8.CrossRefGoogle Scholar
  4. 4.
    Montano-Loza AJ. Skeletal muscle abnormalities and outcomes after liver transplantation. Liver Transpl. 2014;20:1293–5.CrossRefGoogle Scholar
  5. 5.
    van VJLA, Levolger S, de BRWF, van RJ, Metselaar HJ, IJzermans JNM. Systematic review and meta-analysis of the impact of computed tomography–assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation. Am J Transplant. 2016;16:2277–92.CrossRefGoogle Scholar
  6. 6.
    Yadav A, Chang Y, Carpenter S, Silva AC, Rakela J, Aqel BA, et al. Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates. Clin Transpl. 2015;29:134–41.CrossRefGoogle Scholar
  7. 7.
    Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017;66:564–74.CrossRefGoogle Scholar
  8. 8.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39:412–23.CrossRefGoogle Scholar
  9. 9.
    Rolland Y, Czerwinski S, Van Kan GA, Morley JE, Cesari M, Onder G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12:433–50.CrossRefGoogle Scholar
  10. 10.
    Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851–60.CrossRefGoogle Scholar
  11. 11.
    Montano–Loza AJ, Meza–Junco J, CMM P, Lieffers JR, Baracos VE, Bain VG, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10:166–173.e1.CrossRefGoogle Scholar
  12. 12.
    Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant. 2014;14:1870–9.CrossRefGoogle Scholar
  13. 13.
    Carey EJ, Lai JC, Wang CW, Dasarathy S, Lobach I, Montano-Loza AJ, et al. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transpl. 2017;23:625–33.CrossRefGoogle Scholar
  14. 14.
    Merli M, Giusto M, Lucidi C, Giannelli V, Pentassuglio I, Di Gregorio V, et al. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study. Metab Brain Dis N Y. 2013;28:281–4.CrossRefGoogle Scholar
  15. 15.
    Kalaitzakis E, Olsson R, Henfridsson P, Hugosson I, Bengtsson M, Jalan R, et al. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int. 2007;27:1194–201.PubMedGoogle Scholar
  16. 16.
    Merli M, Lucidi C, Giannelli V, Giusto M, Riggio O, Falcone M, et al. Cirrhotic patients are at risk for health care–associated bacterial infections. Clin Gastroenterol Hepatol. 2010;8:979–985.e1.CrossRefGoogle Scholar
  17. 17.
    Tandon P, Ney M, Irwin I, Ma MM, Gramlich L, Bain VG, et al. Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value. Liver Transpl. 2012;18:1209–16.CrossRefGoogle Scholar
  18. 18.
    Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, Baracos VE, Sawyer MB, Pang JXQ, et al. Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol. 2015;6:e102.CrossRefGoogle Scholar
  19. 19.
    Shen W, Punyanitya M, Wang Z, Gallagher D, St.-Onge M-P, Albu J, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol. 2004;97:2333–8.CrossRefGoogle Scholar
  20. 20.
    Durand F, Buyse S, Francoz C, Laouénan C, Bruno O, Belghiti J, et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol. 2014;60:1151–7.CrossRefGoogle Scholar
  21. 21.
    Kaido T, Ogawa K, Fujimoto Y, Ogura Y, Hata K, Ito T, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013;13:1549–56.CrossRefGoogle Scholar
  22. 22.
    Hamaguchi Y, Kaido T, Okumura S, Fujimoto Y, Ogawa K, Mori A, et al. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation. Liver Transpl. 2014;20:1413–9.CrossRefGoogle Scholar
  23. 23.
    Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yagi S, et al. Impact of skeletal muscle mass index, intramuscular adipose tissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation. Transplantation. 2017;101:565–74.CrossRefGoogle Scholar
  24. 24.
    Lee CS, Cron DC, Terjimanian MN, Canvasser LD, Mazurek AA, Vonfoerster E, et al. Dorsal muscle group area and surgical outcomes in liver transplantation. Clin Transpl. 2014;28:1092–8.CrossRefGoogle Scholar
  25. 25.
    Valero V, Amini N, Spolverato G, Weiss MJ, Hirose K, Dagher NN, et al. Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors. J Gastrointest Surg N Y. 2015;19:272–81.CrossRefGoogle Scholar
  26. 26.
    Krell RW, Kaul DR, Martin AR, Englesbe MJ, Sonnenday CJ, Cai S, et al. Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl. 2013;19:1396–402.CrossRefGoogle Scholar
  27. 27.
    Englesbe MJ. Quantifying the eyeball test: Sarcopenia, analytic morphomics, and liver transplantation. Liver Transpl. 2012;18:1136–7.CrossRefGoogle Scholar
  28. 28.
    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Ser A. 2001;56:M146–57.CrossRefGoogle Scholar
  29. 29.
    Dunn MA, Josbeno DA, Tevar AD, Rachakonda V, Ganesh SR, Schmotzer AR, et al. Frailty as tested by gait speed is an independent risk factor for cirrhosis complications that require hospitalization. Am J Gastroenterol. 2016;111:1768.CrossRefGoogle Scholar
  30. 30.
    Carey EJ, Steidley DE, Aqel BA, Byrne TJ, Mekeel KL, Rakela J, et al. Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transpl. 2010;16:1373–8.CrossRefGoogle Scholar
  31. 31.
    Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62:584–90.CrossRefGoogle Scholar
  32. 32.
    Lai JC, Segev DL, McCulloch CE, Covinsky KE, Dodge JL, Feng S. Physical frailty after liver transplantation. Am J Transplant [Internet]. 18:1986. [cited 2018 May 9];0. Available from: http://onlinelibrary.wiley.com/doi/abs/10.1111/ajt.14675.
  33. 33.
    Wang CW, Feng S, Covinsky KE, Hayssen H, Zhou L-Q, Yeh BM, et al. A comparison of muscle function, mass, and quality in liver transplant candidates: results from the functional assessment in liver transplantation study. Transplantation. 2016;100:1692–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Gastroenterology and HepatologyDuke University HospitalDurhamUSA

Personalised recommendations